SCHEMBL3421749

SCHEMBL3421749

Cc1cc(NC(=O)C2(NC(=O)c3ccc(Br)s3)CCOC2)ccc1C(=O)N1CCCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 2/20 0.48
POLB P06746 2/20 0.41
HPGD P15428 1/20 0.41
CTSL P07711 1/20 0.40
CTSB P07858 1/20 0.40
CTSS P25774 1/20 0.40
NPC1 O15118 6/20 0.39
RAB9A P51151 6/20 0.39
MEN1 O00255 6/20 0.39
KMT2A Q03164 6/20 0.39
NFKB1 P19838 3/20 0.39
NFKB2 Q00653 3/20 0.39
RELA Q04206 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
CASP3 P42574 2/20 0.38
SENP7 Q9BQF6 2/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
HTT P42858 1/20 0.37
MAPT P10636 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3771943 1.00 F10 (0.48) F10POLBHPGDCTSLCTSB
SCHEMBL3777662 1.00 F10 (0.48) F10POLBHPGDCTSLCTSB
SCHEMBL3425891 0.93 F10 (0.41) F10POLBHPGDCTSLCTSB
SCHEMBL3429455 0.91 F10 (0.40) F10POLBCTSLCTSBCTSS
SCHEMBL3426110 0.90 F10 (0.51) F10POLBHPGDCTSLCTSB
SCHEMBL3427317 0.90 F10 (0.51) F10POLBHPGDCTSLCTSB
SCHEMBL3425879 0.90 HPGD (0.42) F10POLBHPGDCTSLCTSB
SCHEMBL3426268 0.90 CTSS (0.51) F10POLBHPGDCTSLCTSB
SCHEMBL3425883 0.89 F10 (0.39) F10POLBHPGDCTSLCTSB
SCHEMBL3426427 0.88 MAPK14 (0.39) F10POLBCTSLCTSBCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7732466-B2 Substituted thiophene carboxamides, process for their preparation and their use as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-06-08 US disclosed
US-7732466-B2 Substituted thiophene carboxamides, process for their preparation and their use as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-06-08 US disclosed
US-7732466-B2 Substituted thiophene carboxamides, process for their preparation and their use as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-06-08 US disclosed
US-20060293300-A1 New substituted thiophene carboxamides, process for their preparation and their use as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-12-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060293300-A1 New substituted thiophene carboxamides, process for their preparation and their use as medicaments OTC, TPMT, ABCG2 F10 1901/4885POLB 2488/4885HPGD 4426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.